Published May 2003
| Version v1
Journal article
Carbon-11 labelling of 8{{3-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]-2-hydroxypropyl}oxy} thiochroman, a presynaptic 5-HT1A receptor agonist, and its in vivo evaluation in anaesthetised rat and in awake cat
Description
A new compound, 8{{3-methoxyphenyl)piperazin-1-yl]-2-hydroxypropyl}oxy}thiochroman was labeled via O-methylation with [11C]methyl iodide in good yield and specific activity. Original biological evaluations included (i) the study in anesthetized rat with a β-sensitive intracerebral probe (β-Microprobe), allowing to measure locally the kinetic of the new PET ligand, and (ii) a PET-scan on a conditioned cat maintained awake during the acquisition. In both in vivo techniques, the new ligand did not reveal any specific binding in hippocampus indicating that this radiotracer is not suitable for mapping 5HT1A receptors using positron emission tomography
Additional details
Identifiers
- PII
- S0969805103000271;
Publishing Information
- Journal Title
- Nuclear Medicine and Biology
- Journal Volume
- 30
- Journal Issue
- 5
- Journal Page Range
- p. 541-546
- ISSN
- 0969-8051
- CODEN
- NMBIEO
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 35025199
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- CARBON 11; IN VIVO; LABELLING; LIGANDS; METHYLATION; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS; SYNTHESIS
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CARBON ISOTOPES; CHEMICAL REACTIONS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVEN-ODD NUCLEI; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MEMBRANE PROTEINS; MINUTES LIVING RADIOISOTOPES; NUCLEI; ORGANIC COMPOUNDS; PROTEINS; RADIOACTIVE MATERIALS; RADIOISOTOPES; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2003 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.